A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma
| Image |  |
|---|---|
| Description | scientific article published on 19 December 2018 |
| Author/s |
author: Jennifer L McQuade |
| Publication date | December 19, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |